Presented initial data from Phase 1b study suggesting GT-02287 has a disease-slowing effect consistent with the preclinical models in vivo and the proposed mechanism of action Completed enrollment of ...

GT-02287 improves mitochondrial function by facilitating GCase trafficking to the mitochondria in patient-derived fibroblasts harboring GBA1 mutation BETHESDA, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ...

Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...

Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when the cellular ...

Researchers at the University of Colorado Anschutz Linda Crnic Institute for Down Syndrome (Crnic Institute) have uncovered ...

Sadly, there is no cure for Huntington’s disease. But a couple new research papers suggests this may be about to change.

The new molecules selectively reduced inflammatory signaling in human immune cells without affecting other immune pathways.

Gut microbiome researcher Purna C. Kashyap, MBBS, shares the latest insights on the role of probiotics, disorders of the ...

BETHESDA, Md., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the ...

The U.S. Centers for Disease Control and Prevention has instructed staffers to end all monkey research, according to a report in Science. The decision will affect studies involving some 200 macaques; ...